Managing rheumatic and musculoskeletal diseases in elderly patients present distinct challenges due to age-related physiological changes, comorbidities, polypharmacy and altered treatment responses. Elderly patients often attribute symptoms like joint pain and stiffness to normal aging, leading to underdiagnosis of conditions such as rheumatoid arthritis, polymyalgia rheumatica or giant cell arteritis. Comorbidities can obscure or mimic rheumatic diseases, delaying diagnosis and increasing the risk of complications. Over-reliance on corticosteroids exacerbates risks like osteoporosis, diabetes and infections, while polypharmacy introduces the potential for drug interactions and non-adherence. Immunosuppressive therapy elevates infections risk, necessitates proactive screening, vaccination and close monitoring. Cognitive impairment and sensory deficits can hinder accurate symptom reporting and treatment adherence, further complicating care. Differentiating osteoarthritis from inflammatory arthritis is particularly challenging but critical for appropriate treatment. Early recognition, comprehensive care and individualised treatment plans can significantly improve outcomes at this difficult-to-treat category of patients.